rBIO Doubles Insulin Output Over Legacy Manufacturing Methods, Putting Company on Track to Reduce Insulin Costs by 30%
/PRNewswire/ -- rBIO, an early-stage synthetic biology company focused on reducing the cost of increasingly costly biologic therapies, announced refinement of...
Source: prnewswire.com